Latest News in the pharma Industry

Top Stories

Dutch Pharma Qiagen Plans to Buy French Ipsogen

Dutch Pharma Qiagen Plans to Buy French Ipsogen

16 Jun 2011

The transaction will give Qiagen access to a range of assays covering 15 biomarkers for the diagnosis, prognosis and monitoring of blood cancers.

Read more 
Pfizer Goes to Court to Protect Viagra Patent

Pfizer Goes to Court to Protect Viagra Patent

16 Jun 2011

Pfizer began its court proceedings in Virginia on Wednesday to try to extend its patent on the erectile dysfunction drug Viagra.

Read more 
Arecor and GSK Sign Vax License Deal

Arecor and GSK Sign Vax License Deal

15 Jun 2011

GSK and Arecor will work to develop new approaches that could offer significant improvements to the administration of several vaccines in development.

Read more 
Sartorius and Südpack Ink Polymer Films Deal

Sartorius and Südpack Ink Polymer Films Deal

15 Jun 2011

The two companies will also collaborate on the development of multi-layer films with improved product characteristics to be employed in single-use bioreactors. The first product innovations from are expected in approximately one year.

Read more 
Lilly and Synthes Sign Collaboration Agreement

Lilly and Synthes Sign Collaboration Agreement

15 Jun 2011

Eli Lilly and Co. has signed a deal with Synthes to co-promote the bone drug Forteo and develop other potential orthopedic treatments.

Read more 
FDA Works to Lessen Drug Shortage Impact

FDA Works to Lessen Drug Shortage Impact

14 Jun 2011

FDA says the number of drug shortages has nearly tripled over the last six years, jumping from 61 drug products in 2005 to 178 in 2010.

Read more 
Canada Needs Better Patent Protection

Canada Needs Better Patent Protection

14 Jun 2011

Sanofi-Aventis chief executive Chris Viehbacher has warned that Canadian pharmaceutical companies need more comprehensive patent protection.

Read more 
Merck Serono and Affectis Sign Licensing Agreement

Merck Serono and Affectis Sign Licensing Agreement

14 Jun 2011

Merck Serono will have worldwide exclusive rights to develop and commercialise selected compounds. The contract also includes a research collaboration focusing on P2X7 antagonist optimisation.

Read more 
Kareus & Quintiles Ink Strategic Development Pact

Kareus & Quintiles Ink Strategic Development Pact

14 Jun 2011

Under the terms of the alliance, Quintiles will make an undisclosed investment in Kareus through an equity investment and access to clinical service on a shared-risk basis.

Read more 
UK Pledges £814M for Child Vaccines

UK Pledges £814M for Child Vaccines

14 Jun 2011

The UK's promise for more funding follows last week's announcement that major pharmaceutical companies would make cuts to the prices of their vaccines in the developing world.

Read more 
Hovione and Particle Sciences Ink Drug Solubilization Pact

Hovione and Particle Sciences Ink Drug Solubilization Pact

10 Jun 2011

Hovione and Particle Sciences Inc have inked a collaboration deal to speed development projects targeting poorly water-soluble drugs.

Read more 
Celerion Sites Certified for Brazilian Market

Celerion Sites Certified for Brazilian Market

10 Jun 2011

Celerion's several facilities have been approved by the Brazilian regulators to enter the Brazilian market.

Read more